What Happened? Shares of genomics company Illumina (NASDAQ:ILMN) fell 3.2% in the afternoon session after reports emerged of ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. Featuring daily updates ...

Investors in Illumina Inc (Symbol: ILMN) saw new options become available today, for the March 2026 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the ...

Illumina, Inc. ILMN reported better-than-expected earnings for the second quarter on Thursday. The company posted quarterly earnings of $1.19 per share which beat the analyst consensus estimate of ...

RBC Capital analyst Conor McNamara maintained a Buy rating on Illumina today and set a price target of $124.00. The company’s shares closed today at $97.82. Take advantage of TipRanks Premium at 50% ...

Have you evaluated the performance of Illumina's (ILMN) international operations for the quarter ending June 2025? Given the extensive global presence of this genetic testing tools company, analyzing ...

Baron Funds, an investment management company, released its “Baron Global Advantage Fund” investor letter for the second quarter of 2025. A copy of the letter can be downloaded here. In the second ...